Micropulse diode vs conventional green laser treatment in clinically significant diabetic macular oedema

ISRCTN ISRCTN90646644
DOI https://doi.org/10.1186/ISRCTN90646644
Secondary identifying numbers MP1
Submission date
25/07/2007
Registration date
30/08/2007
Last edited
28/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Victor Chong
Scientific

Laser and Retinal Research Unit
King's College Hospital
Denmark Hill
London
SE5 9RS
United Kingdom

Email victor@eretina.org

Study information

Study designProspective randomised double-masked controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesMicropulse diode laser has been used for patients with clinically significant diabetic macular oedema. It has not been directly compared with the standard treatment with green laser. In this study, we are going to perform a prospective randomised double-masked controlled trial to compare these two treatment modalities.
Ethics approval(s)South East London Ethical Committee, approved on 14 August 2003(ref: 07-03-159)
Health condition(s) or problem(s) studiedDiabetic macular oedema
InterventionMicropulse diode vs conventional green laser treatment
Intervention typeOther
Primary outcome measureVisual acuity at 12 months.
Secondary outcome measuresThe following will be assessed at 12 months:
1. Contract sensitivity
2. Central retinal thickness
3. Visible laser scars in macula
Overall study start date01/01/2005
Completion date01/01/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexBoth
Target number of participants100
Key inclusion criteria1. Patients with clinically significant macular edema due to diabetes in at least one eye
2. Able to understand and consent to the study
3. Vision acuity on study eye better than 20/200
Key exclusion criteria1. Ocular surgery within the past 6 months
2. Any laser surgery in the study eye
3. Any other ocular diseases in the study eye that can alter vision during the study period
4. Poor diabetic control with HBA1c >12
Date of first enrolment01/01/2005
Date of final enrolment01/01/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Laser and Retinal Research Unit
London
SE5 9RS
United Kingdom

Sponsor information

King's College Hospital (UK)
University/education

Denmark Hill
London
SE5 9RS
England
United Kingdom

Email victor.chong@kch.nhs.uk
ROR logo "ROR" https://ror.org/01qz4yx77

Funders

Funder type

Government

Ophthalmic Fund within the King's College Hospital NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2009 Yes No